Effect of modafinil for prevention of cognitive and sociological dysfunction after sleeve gastrectomy

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141009019470N76

Enrollment

Registered

2018-09-06

Start date

2018-09-01

Completion date

Unknown

Last updated

2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sleeve gastrectomy. Other complications of other bariatric procedure

Interventions

Intervention 1: Intervention group:patients received 2 tablets of modafinil 100 mg two hours before the operation. Intervention 2: Control group: patients received 2 tablets of placebo two hours b

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Patients who are candidate for elective sleeve gastrectomy ASA I-II age between 18-45 years old

Exclusion criteria

Exclusion criteria: Active and uncontrolled diseases of the cardiovascular system. Gastrointestinal diseases. Liver disease. kidney Diseases. Psychological and mental illness. Neurological diseases. Taking psychiatric medications. opium addiction

Design outcomes

Primary

Measure	Time frame
Depression and Anexiety. Timepoint: The day before the surgery and after leaving the recovery room. Method of measurement: Depression and Anxiety Scale, DASS-21.;Cognitive problems. Timepoint: The day before the surgery and after leaving the recovery room. Method of measurement: The Addenbrooke's Cognitive Examination (ACE).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKambiz Golestani

Shiraz University of Medical Sciences

masihifarzaneh@yahoo.com+98 71 3647 4270

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026